ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+10.24%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$711M
AUM Growth
+$711M
(-25%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-39.53%
Top 10 Holdings %
Top 10 Hldgs %
65.39%
Holding
37
New
13
Increased
1
Reduced
10
Closed
13
Top Buys
| 1 |
Medpace
MEDP
|
$64.4M |
| 2 |
Illumina
ILMN
|
$57.4M |
| 3 |
Tenet Healthcare
THC
|
$51.3M |
| 4 |
Envista
NVST
|
$43.3M |
| 5 |
Exact Sciences
EXAS
|
$27.2M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$67.2M |
| 2 |
DexCom
DXCM
|
$66M |
| 3 |
McKesson
MCK
|
$53.8M |
| 4 |
AbbVie
ABBV
|
$48.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$45.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Medpace
MEDP
$13.4B
| $64.4M | 8.92% | +192,842 | New | +$64.4M |
|
2
Elanco Animal Health
ELAN
$9.12B
| $62.6M | 8.68% | 4,263,343 +1,034,904 | +32% | +$15.2M |
|
|
3
Illumina
ILMN
$15.8B
| $57.4M | 7.95% | +440,000 | New | +$57.4M |
|
|
4
Tenet Healthcare
THC
$16.3B
| $51.3M | 7.11% | +308,940 | New | +$51.3M |
|
5
Acadia Healthcare
ACHC
$2.12B
| $50.9M | 7.05% | 802,151 -36,924 | -4% | -$2.34M |
|
|
6
Envista
NVST
$3.52B
| $43.3M | 5.99% | +2,189,369 | New | +$43.3M |
|
7
Intuitive Surgical
ISRG
$170B
| $35.4M | 4.9% | 72,001 -48,985 | -40% | -$24.1M |
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $35M | 4.85% | 1,943,790 -1,356,395 | -41% | -$24.4M |
|
9
Oscar Health
OSCR
$4.31B
| $34.2M | 4.74% | 1,611,909 -220,347 | -12% | -$4.67M |
|
10
Danaher
DHR
$147B
| $30.6M | 4.24% | 110,000 -77,011 | -41% | -$21.4M |
|
11
Glaukos
GKOS
$5.5B
| $28.4M | 3.93% | 217,674 -290,482 | -57% | -$37.8M |
|
|
12
Exact Sciences
EXAS
$8.98B
| $27.2M | 3.77% | +399,871 | New | +$27.2M |
|
13
Insulet
PODD
$23.9B
| $25.6M | 3.55% | 110,000 -154,041 | -58% | -$35.9M |
|
14
Merit Medical Systems
MMSI
$5.36B
| $25M | 3.46% | +253,000 | New | +$25M |
|
15
Twist Bioscience
TWST
$1.63B
| $23M | 3.19% | 510,000 -16,455 | -3% | -$743K |
|
16
Axsome Therapeutics
AXSM
$6.05B
| $22.7M | 3.14% | +252,266 | New | +$22.7M |
|
17
Geron
GERN
$893M
| $15.2M | 2.11% | +3,351,000 | New | +$15.2M |
|
18
Sanofi
SNY
$121B
| $15.1M | 2.09% | +261,741 | New | +$15.1M |
|
19
Brookdale Senior Living
BKD
$1.83B
| $14.9M | 2.07% | 2,197,578 -3,604,363 | -62% | -$24.5M |
|
20
Insmed
INSM
$28.8B
| $13.1M | 1.82% | 180,000 -233,196 | -56% | -$17M |
|
21
Acadia Pharmaceuticals
ACAD
$4.38B
| $11.5M | 1.6% | +750,000 | New | +$11.5M |
|
22
Myriad Genetics
MYGN
$593M
| $11M | 1.52% | +401,859 | New | +$11M |
|
23
Indivior
INDV
$3.03B
| $8.24M | 1.14% | +845,470 | New | +$8.24M |
|
|
BCAX
24
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $5.09M | 0.71% | +200,000 | New | +$5.09M |
|
|
25
AbbVie
ABBV
$372B
| – | – | -284,657 | Closed | -$48.8M |
|